RNU6-1288P

Across TCGA pan-cancer cohorts, RNU6-1288P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-1288P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-1288P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1288P expression acts as an unfavorable survival marker.

BLCA, STAD, and LUSC are the cancer types where RNU6-1288P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.051	0.720	<.001	144	view →
STAD	OS	Tertile	All	0.061	0.731	<.001	81	view →
LUSC	OS	Tertile	All	0.181	0.776	.004	72	view →
OV	OS	Tertile	IV	0.028	0.759	.002	36	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-1288P–BLCA (OS)

Open the BLCA breakdown →